Antidiabetics Market Size, Share, Growth, Trends, Segmentation and Forecast by 2025

Antidiabetics is commonly used to manage diabetes with the help of antidiabetic agent. It helps a person with diabetes, to control their level of glucose (sugar) in the blood. It mainly includes insulin and the oral hypoglycemic agents. There are different classes of anti-diabetic drugs and their selection depends on the nature of the diabetes, age and situation of the person, as well as on some other factors.

The leading market players mainly include:

Global antidiabetics market report covers prominent players like Eli Lilly, Novartis, Bayer Corporation, Johnson & Johnson, Pfizer, AstraZeneca, Bristol-Myers Squibb, Oramed Pharmaceuticals, Novo Nordisk, Merck, Boehringer Ingelheim, Takeda Pharmaceutical, Sanofi, and others.

The detailed segments and sub-segment of the market are explained below:

By Product:

  • Rapid Acting Insulin
  • Long Acting Insulin
  • Premixed Insulin
  • Short Acting Insulin
  • Intermediate Acting Insulin

By Drug Class:

  • Alpha-Glucosidase Inhibitors
  • Biguanides, Sulphonylureas
  • GLP-1 Agonist
  • Meglitinides
  • DPP-4 Inhibitors
  • SGLT-2
  • Thiazolidinedione

By Route of Administration:

  • Insulin Syringe/Insulin Pen
  • Insulin Pump
  • Intravenous Infusion
  • Oral

Get Full information of This Report@

More Report: